Search

Displaying results 8411 - 8420 of 8553 in total
  1. Drug

    C326

    go.drugbank.com/drugs/DB06017
    Experimental

    C326 is an investigational compound under investigation in clinical trial NCT00353756 (Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease) for the treatment of Crohn's Disease. The drug is co...

  2. Drug

    XL844

    go.drugbank.com/drugs/DB05149
    Investigational

    XL844 is investigated for the use and treatment solid tumors. XL844 is a solid. XL844 is a potent inhibitor of the checkpoint kinases CHK1 and CHK2, which induce cell cycle arrest in response to a variety of DNA damaging agents. Known dr...

  3. Drug

    Opaganib

    go.drugbank.com/drugs/DB12764
    Investigational

    Opaganib, also known as ABC294640, is a selective sphingosine kinase-2 (SK2) (https://go.drugbank.com/polypeptides/Q9NRA0) inhibitor that is orally administered. This drug has potential anticancer, anti-inflammatory, and antiviral activi...

  4. Drug

    Filanesib

    go.drugbank.com/drugs/DB06040
    Investigational

    Filanesib is a potent Kinesin Spindle Protein (KSP) inhibitor that caused marked tumor regression in preclinical models of human solid tumors and human leukemias, often leading to durable responses.

  5. Drug

    Ferulic acid

    go.drugbank.com/drugs/DB07767
    Investigational

    Categories: Analgesics, Non-Narcotic
  6. Drug

    Zosurabalpin

    go.drugbank.com/drugs/DB21539
    Investigational

    Zosurabalpin has a monoisotopic molecular weight of 790.36 Da.

  7. Drug

    Zonampanel anhydrous

    go.drugbank.com/drugs/DB20448
    Investigational

    Zonampanel anhydrous has a monoisotopic molecular weight of 331.06 Da.

  8. Drug

    Risovalisib

    go.drugbank.com/drugs/DB21474
    Investigational

    Risovalisib has a monoisotopic molecular weight of 598.19 Da.

  9. Drug

    Lisofylline

    go.drugbank.com/drugs/DB12406
    Investigational

    Lisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus.

    Categories: Analgesics, Non-Narcotic
  10. Drug

    Melitracen

    go.drugbank.com/drugs/DB13384
    Investigational

    Categories: Non-Selective Monoamine Reuptake Inhibitors